Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult Subjects

NCT00978614 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Neramexane

Sponsor

Merz Pharmaceuticals GmbH